Plazomicin may be well-suited to play a critical role in biodefense preparedness --Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE